Characterization of the interleukin‐17 isoforms and receptors in lesional psoriatic skin

@article{Johansen2009CharacterizationOT,
  title={Characterization of the interleukin‐17 isoforms and receptors in lesional psoriatic skin},
  author={Claus Johansen and Pernille Autzen Usher and Rasmus Boye Kjellerup and Dorthe Lundsgaard and Lars Iversen and Knud Kragballe},
  journal={British Journal of Dermatology},
  year={2009},
  volume={160}
}
Background  Th17 cells are a lineage of proinflammatory T helper cells producing interleukin (IL)‐17. The importance of Th17 cells in inflammation and autoimmunity has now been recognized. The IL‐17 cytokine family consists of six isoforms (IL‐17A–IL‐17F) whereas five members of the IL‐17 receptor (IL‐17R) family have been identified (IL‐17RA–IL‐17RE). 
Pathogenic role of IL-17 in psoriasis and psoriatic arthritis.
TLDR
Preliminary results are highly promising for all anti-IL17 agents, creating fair expectations on this class of agents as the new effective therapeutic approach for the treatment of psoriasis. Expand
IL‐25 in allergic inflammation
TLDR
The authors' knowledge on IL‐25 will pave the pathway for targeting this cytokine in inflammatory diseases, and the unsolved questions will be discussed. Expand
Interleukin-17A and Keratinocytes in Psoriasis
TLDR
This review focuses on IL-17A and keratinocyte interaction regarding psoriasis pathogenesis, which results in characteristic histopathological features, such as epidermal hyperproliferation, intraepidermal neutrophilic microabscess, and dermal CCR6+ cell infiltration. Expand
Interleukin‐17A: a unique pathway in immune‐mediated diseases: psoriasis, psoriatic arthritis and rheumatoid arthritis
TLDR
Experimental evidence points to the importance of the cytokine interleukin‐17A in the pathogenesis of several immunoinflammatory diseases including psoriasis, psoriatic arthritis and rheumatoid arthritis, although levels of response are not predicted by pre‐clinical findings. Expand
Targeting the Th17 pathway in psoriasis
TLDR
The preclinical and clinical evidence implicating Th17 cells in psoriasis and the therapeutic approaches, approved or under investigation, to target this pathway in Psoriasis are summarized. Expand
IL-17 in Chronic Inflammation: From Discovery to Targeting.
TLDR
With a fruitful outlook, drug registration has now been granted for psoriasis psoriatic arthritis and ankylosing spondylitis, and IL-17 bears great potential in a growing number of conditions. Expand
Persistence of interleukin (IL)‐17A+ T lymphocytes and IL‐17A expression in treatment‐resistant psoriatic plaques despite ustekinumab therapy
TLDR
Interestingly, most ‘responders’ to biologics, still have areas of persistent disease involvement, often presenting with moderate-to-severe psoriatic plaques, localized to one or a few locations on the body while under treatment. Expand
Signalling of multiple interleukin (IL)‐17 family cytokines via IL‐17 receptor A drives psoriasis‐related inflammatory pathways
TLDR
Several IL-17 ligands signaling through IL- 17RA are over-expressed in Psoriasis skin and induce similar psoriasis-related inflammatory pathways demonstrating their relevance in relation to therapeutic intervention in psOriasis. Expand
IL-17 family member cytokines: regulation and function in innate immunity.
TLDR
This review will highlight recent advances in the field of IL-17 family member cytokines and will predominantly focus on the innate regulation and function ofIL-17, IL- 17F, and IL-25. Expand
The role of Th17 cells in psoriasis.
TLDR
The immunopathology role of Th 17 cells and functions of the related cytokines in the psoriasis is demonstrated to get a better understanding of the inflammatory mechanisms mediated by Th17 cells in this disease. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 55 REFERENCES
T-helper 17 cells in psoriatic plaques and additional genetic links between IL-23 and psoriasis.
  • A. Blauvelt
  • Biology, Medicine
  • The Journal of investigative dermatology
  • 2008
TLDR
T-helper 17 (Th17) cells are a newly appreciated T-cell subset, distinct from both Th1 and Th2 cells, that have been implicated in the pathogenesis of psoriasis and other autoimmune inflammatory diseases and serves as a key master cytokine regulator for these diseases. Expand
Interleukin-17 family members and inflammation.
TLDR
Increasing evidence shows that IL-17 family members play an active role in inflammatory diseases, autoimmune diseases, and cancer, which places IL- 17 family members and their receptors as potential targets for future pharmacotherapy. Expand
Mechanism of interleukin‐25 (IL‐17E)‐induced pulmonary inflammation and airways hyper‐reactivity
  • T. Sharkhuu, K. Matthaei, +4 authors P. Foster
  • Medicine
  • Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology
  • 2006
TLDR
Although IL‐25 up‐regulates IL‐13 in the lung, the contribution of this and other type 2 cytokine signalling pathways to the induction and persistence of airways hyper‐reactivity (AHR) and allergic inflammation are unclear. Expand
Pathophysiology of psoriasis: Recent advances on IL-23 and Th17 cytokines
TLDR
This review focuses on the numerous recent studies on the roles of IL-23 and Th17 cells in the pathogenesis of psoriasis and suggests that future targeting of these key cytokines is likely to lead to dramatic clinical improvement in patients with Psoriasis. Expand
IL-17 cytokine family.
TLDR
The potent inflammatory activity and its association with various human disease states suggest this new cytokine family as an important contributor to the pathophysiology of human disease conditions, in particular the pulmonary diseases. Expand
Expression of IL-17 homologs and their receptors in the synovial cells of rheumatoid arthritis patients.
TLDR
The data suggest that additional IL-17-related molecules and their receptors have been discovered and may also contribute to RA pathogenesis should also be considered as targets for immune modulation in the treatment of RA joint inflammation. Expand
Interleukin-23 Promotes a Distinct CD4 T Cell Activation State Characterized by the Production of Interleukin-17*
TLDR
Evidence is presented that murine IL-23, which is produced by activated dendritic cells, acts on memory T cells, resulting in elevated IL-17 secretion, which suggests that during a secondary immune response, IL- 23 can promote an activation state with features distinct from the well characterized Th1 and Th2 profiles. Expand
TH-17 cells in the circle of immunity and autoimmunity
TLDR
New data suggest a dichotomy between CD4+ regulatory T cells positive for the transcription factor Foxp3 and TH-17 cells, whereas IL-6 inhibits TGF-β-driven Foxp 3 expression and together with T GF-β induces TH- 17 cells. Expand
IL-23 drives a pathogenic T cell population that induces autoimmune inflammation
TLDR
Using passive transfer studies, it is confirmed that these IL-23–dependent CD4+ T cells are highly pathogenic and essential for the establishment of organ-specific inflammation associated with central nervous system autoimmunity. Expand
Cutting Edge: IL-17D, a Novel Member of the IL-17 Family, Stimulates Cytokine Production and Inhibits Hemopoiesis1
TLDR
A novel cytokine termed IL-17D was cloned using nested RACE PCR and demonstrated an inhibitory effect on hemopoiesis of myeloid progenitor cells in colony formation assays. Expand
...
1
2
3
4
5
...